Several recent studies demonstrated that urinary tubular damage markers, such as KIM-1, NGAL and L-FABP, may have the potential to be clinical markers for identifying the development or progression of diabetic nephropathy [27]–[30]. The gene discussed is LCN2; the disease is diabetic kidney disease.